Bo Zhang
Gästforskare vid Institutionen för läkemedelskemi; Translationell avbildning med PET
- E-post:
- bo.zhang@ilk.uu.se
- Besöksadress:
- Dag Hammarskjöldsv 14C, 3tr
- Postadress:
- Dag Hammarskjöldsv 14C, 3tr
751 83 Uppsala
- ORCID:
- 0000-0002-9199-1115
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
Denna text finns inte på svenska, därför visas den engelska versionen.
My research mainly focuses on the developing of new F18 radiotracers and new methods of F18 radiolabelling
Nyckelord
- f18
- pet
- radiolabelling
- radiotracers
Publikationer
Senaste publikationer
- [18F]MK-7246 for Positron Emission Tomography Imaging of the Beta-Cell Surface Marker GPR44 (2023)
- Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells. (2023)
- Imaging of fibrogenesis in the liver by [18F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β (2023)
- PET Imaging of GPR44 by Antagonist [C-11]MK-7246 in Pigs (2021)
- Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69 (2021)
Alla publikationer
Artiklar
- [18F]MK-7246 for Positron Emission Tomography Imaging of the Beta-Cell Surface Marker GPR44 (2023)
- Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells. (2023)
- Imaging of fibrogenesis in the liver by [18F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β (2023)
- PET Imaging of GPR44 by Antagonist [C-11]MK-7246 in Pigs (2021)
- Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69 (2021)
- Lead compound identification from first-in-class high affinity Affibody molecules binders towards DGCR2
- Preclinical evaluation of Affibody molecule 18F-TZ-ZAM106 for PET imaging of DGCR2
- Positron Emission Tomography imaging of CD69 in a murine model of rheumatoid arthritis
